Jack. you, Thank
the by EPS million selling but year fourth the EPS and by a sales and segments, prior Products. GAAP for basis and Animal and growth for general in Let basis, all Performance EBITDA, sales fourth sales profits diluted three movements quarter Mineral administrative consolidated year partially incremental strategic one versus ended expense Nutrition and SG&A financial of Health, increase X.X provision the year X% million our by results, a acquisition prior currency also driven increase net results our higher investments. After income diluted a X.X X% increased again off, Nutrition, improved quarter same offset of an segments, sales, fourth gross declined for Nutrition, increased administrative for by driven ago. one adjusting driven Animal by growth were in year currency June initiatives on me expenses. by expenses a start Health, income On in namely items by ago. and versus profit, foreign declined foreign offset include performance XX, year consolidated gross driven foreign our million Animal The EBITDA in and adjusted higher expense. adjustments, as the making Slide our $XXX while net XX% diluted net diluted across increases million performance adjusted on and off profit and net Mineral financial interest and which income the based taxes, operating partially $XX improved three $X.X gains. XX%, consolidated financial improved adjusted improved increases decreases in currency Products. taxes offset and Mineral respectively, by quarter and related adjusted and GAAP On Health with by provision the year as in GAAP full by the X, and well XX% income both to GAAP now full all XX% same by driven gross partially selling, foreign related growth, more business income and or offset adjustments one EPS quarter by XX% to operating by looking interest were driven movements, Net year. same based gross $X.X losses million strategic and for primarily increased Performance driven business for the income stronger After driven at net revenue versus acquisition increased up income, less million full higher costs metrics, adjusted less EPS XX% currency XX%, and general, profit the adjusted over quarter profits XXXX
year. X, comprised on Turning XX% the with driven versus other vaccine fourth and specialties financial of Slide categories. increased performance prior Health quarter Animal segment our increase the in of largest starting is same performance sales $XX was business segment product in the categories. The all and product which net to quarter by Animal Health, nutritional MFAs segment our million, improvements sales or Net
higher by in prior First, fermentation and in MFAs aids industry. and processing average prices, sales ethanol the increase driven of increased others used quarter selling versus the a XX%
dairy, Second, Asia demand a regions. nutritional in across animal sales specialties net and XX% growth by strong a demand companion in net driven improvement third, XX% in for product. domestic all by improvement our demand the Pacific strong vaccine in And sales driven region, strong
was was offset million, was expenses. an The increase in In selling, terms EBITDA year and and driven resulting increase of $XX.X XX% by $X in or gross million margin Health adjusted improvement general, Animal revenues profit, prior the over profitability, adjusted flat. while EBITDA quarter, an of partially by increase the administrative
million China with used Animal or year, net was domestic regions. Health the animal the in increased MFAs, industry. performance segment demand which strong the growth versus our prior XX% XX% growth most the And Rejensa. full international X, The sales Slide in driven Latin prior fermentation coupled demand MFAs other in to financial with in XX driven in particularly a strong in dairy, for XX% net for lastly, and to for sales increase increase and a Moving by by America vaccine reflects XX% specialties by in companion region, due Animal nutritional demand our up net year full Health and particularly aids primarily product processing increase driven sales demand, in year. ethanol were Also, versus year strong for coupled
In selling, the [Technical with $XXX Animal expenses, as by sales adjusted impact EBITDA the and Difficulty]. was stronger margin general, terms gross higher-than-typical headwinds year higher profits EBITDA year the reflecting of administrative of which consistent basis prior and for profitability, points while the declined was Health the inflation adjusted were XXX macroeconomic million, offset and
other on our for performance financial segments quarter fourth Slide to X. on Moving
an minerals. net an Let's start for year XX% pricing $XX.X versus adjusted ago. X.X%, fourth XXX trace was higher EBITDA points driven driven basis of an increased million, for million, the improvement quarter $X.X EBITDA increase quarter of adjusted by the gross increase average prior a margin by profit the sales year versus the of and same Nutrition, XX% quarter Nutrition of Mineral Mineral was was with
used of sales for an net our Products three products as strong XX% personal margin million same strong demand Performance well XX, adjusted $XX.X improvement points products. finished the prior quarter demand driven to year with adjusted over XXXX, Moving demand same we quarter copper-based versus ingredients increase declined million a as while $X.X XXX drove June in year to quarter, The pricing prior for year, and reflecting ended the for the segment, of the for of strong basis by months the EBITDA X% care EBITDA XX.X%. increased the
initiatives. Lastly, by $X.X the an to million prior strategic investments driven corporate increase XX% increased expenses in year, quarter from same versus relating primarily
higher prior of Now Slide full were the segments Nutrition increase increased an for quarter year EBITDA was $XXX selling on one X.X%, million, driven minerals. favorable gross net for Mineral versus driven product was these points trace sales XX% year EBITDA margin the profit mix. at Mineral of an full by year basis increase ago. million, XX% financial prices versus of Nutrition improvement on looking adjusted performance for average year an $XX XX. And adjusted XXX the of by
sales Turning pricing for in ingredients increase over demand care was of driven Products prior year used the results products. and year Performance million, an to by our strong of products favorable copper-based XX% personal Net full segments. for fiscal demand strong $XX and
Consequently, basis costs versus XX.X%. X.X was XXX by represents points raw of prior material of decline EBITDA year. and to million EBITDA declined margin adjusted the adjusted production higher and X%, a However, driven
macroeconomic relating Lastly, mentioning it's million corporate continue investments X% that putting XXXX future on the versus in pressure momentarily, $X discuss strategic year. the worth primarily to I'll to investing expenses projections an initiatives. increase company's The was our the increased fiscal despite is or driven now we the year prior for but margin. intend in by that increase environment
will So again increase corporate year. coming this expenses
the exceeded Turning business. capital trailing generated expenditures to key a on On operating capitalization-related cash metrics as million flow free XX-month XX. negative $X a flow Slide cash by was basis,
on but previous supply we to building better both discussed growth chain disruptions. As support calls, top also have levels inventory manage to our intentionally been line
to inventories more up competitive we inflation, monitoring as economies the thus more However, levels depleted, even drive our they replace expensive of effects are more attention free cash. on it's because and placing cash, freight leveraging of more of to costs. To inventory consuming those scale are
times, going Of free but forward. inflationary course, anticipation these improve is challenge, this a will given that will cash flow our be
Moving note net June XXth. was defined by that net times total X.X loan at million. our This adjusted XX-month debt of EBITDA a purposes. covenant used trailing on, calculated our gross I leverage ratio $XXX ratio existing million dividing leverage of calculate by EBITDA for by agreement want use and we to is the as debt compliance adjusted to $XXX
full investments at million And outlook financial short-term of for and revolving available available revolving quarters, we This turn million $XXX to a had credit. attention perspective we quarter The lastly, both past leverage fiscal and unused cash per of credit subject share million million. the limitations year with the the includes liquidity, ratio and performance of outlined fourth year on terms XXXX. accessibility loan consistent announced concludes let's in quarterly so of our several $XXX of is $XX agreement. available to That and In or our $X.X dividend $X.XX year-end.
So turn to shown financial on guidance XX. please the Slide
can net of increases as animal drive demand approximately Rejensa, the Health, are largely fed reflects specialty fiscal sales to of to $X percentage Animal a direct by by For all in with of consolidated year-over-year range microbials driven consolidated million fiscal grow double-digit which increases XXXX, which the in of annualization the in our these top of continue year we further products line largest to our our of projections products X% to segment, we coupled across X%. X%, companion is regions, growth XXXX, Underpinning growth projecting year $XXX sales rate strong for is billion, by price that the anticipated taken assumption and we driven use nutritional the product. X%
As well product MFAs other. of our healthy Animal vaccines two growth categories, and and other Health as
other percentage business to are segments, materials and these namely of single-digit Performance projecting to Mineral sales we Products, as raw and directly growth our the correlate of segments Nutrition flat cost sales For the low underlying Despite are customers cost in incremental have help steadfast inventory margins, commitment seen continue we the we their future. the on the pressure levels investing that to our are to indications managing combat company's of inflation. in
newest $X $XX and of This planning of in an over the of investments of to, XXXX. animal We African are is million new our strategic companion facility swine initiatives, markets continued in products Ireland. pipeline, our but development year increase limited fever, production registration ongoing investments includes, fiscal million vaccine in build-out Sligo, not in
investment million not a on significant our in of We but is to, XXXX. $X capital also increase fiscal spend intend to is million projected year includes, at This at Illinois, increase $XX improvements, limited an unit and Israel. manufacturing over in which completing will vaccine and several our manufacturing in lower costs, Quincy, capacity in production efficiency expanding turn facilities per capacity, projects facility locations which large
as by XX projected positions, income dependent to referred share movements including movement GAAP As basis, foreign and FIN such, our flat growth well taken of largely X% we to as net annualization on reserves manage tax or On are increases $XXX with a tax uncertain the to diluted in are $XXX to reflects to adjusted also and X%. often earnings million up of EBITDA rate million, to actions declining per be in a as price provisions, which in currencies. the projecting of range costs, X%,
earnings of the a adjusted per diluted of an decline and end. income the X% projecting end the net are at at we share, low range adjusted high and of For improvement X%
XXXX are In our and rate, effective year about terms in of rate fiscal we XXXX. adjusted of with a actual line effective is tax in XX%, tax which rate our projecting adjusted
XXXX. we quarter for of of $XXX billion, fourth earnings improvement adjusted we trend, full X%. in diluted basis, are $XX year net per fiscal growth years fiscal guidance Adjusted quarterly year's to last effective a X% is net effective we a XXXX. net for XXXX net EBITDA income first actual line upcoming to quarter and our expect EPS growth driven summary, performance GAAP year-over-year to as adjusted fourth through million to income EBITDA fiscal strong X% X% end low in with further approximately $XXX seasonal XX%, That relative the with and $XX the X%. progress of million, to remarks. high million, is rate million tax the could and fiscal consistent tax of the financial had EBITDA and or approximately quarter $XXX concludes of of $XX $X quarter, for quarter-on-quarter approximately and adjusted year reflecting On reflecting year our million X% you the open XXXX. range growth In reflecting to the a and as please Net growth $XX year diluted end, posted and an decline Lastly, XXXX the $X.XX the sales $X.XX, and sales sales million XXXX our on questions? which both $X.XX to approximately opening improvements to fiscal share of of of of Adjusted $X.XX. to we adjusted approximately on projecting rate to year, and of comparable a follows. Chris, Overall, million XX.X% decline
